NCT03313583

Brief Summary

Describe the epidemiologic profile and clinical context of transfusion recipients in France. Describe the clinical context of transfusion. Describe the characteristics of the transfusion prescriptions, the use of blood products and the main indications for transfusion. Describe transfusion practice according the type of hospital stay.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
4,720

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2011

Shorter than P25 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2011

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2011

Completed
5.8 years until next milestone

First Submitted

Initial submission to the registry

September 29, 2017

Completed
19 days until next milestone

First Posted

Study publicly available on registry

October 18, 2017

Completed
Last Updated

October 18, 2017

Status Verified

October 1, 2017

Enrollment Period

Same day

First QC Date

September 29, 2017

Last Update Submit

October 17, 2017

Conditions

Blood Product Transfusion for All ConditionsTraumaSurgical Blood LossHematologic Diseases

Outcome Measures

Primary Outcomes (3)

  • Number of red blood cell concentrates received

    transversal study

    1 day (cross sectional)

  • Number of platelet concentrates recevied

    transversal study

    1 day (cross sectional)

  • Number of plasma units received

    transversal study

    1 day (cross sectional)

Study Arms (1)

Blood product recipients

All patients who received at least one blood product on the day of the study

Procedure: Transfusion of blood products

Interventions

Transfusion of blood productsPROCEDURE
Blood product recipients

Eligibility Criteria

Sexall(Gender-based eligibility)
Gender Eligibility DetailsAll blood products recipients
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

french population of recipients

You may qualify if:

  • Transfusion with at least one blood product on the day of the study.

You may not qualify if:

  • None

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Fillet AM, Desmarets M, Assari S, Quaranta JF, Francois A, Pugin A, Schuhmacher A, Lassale B, Monnet E, Cabre P, Legrand D, Binda D, Djoudi R. Blood products use in France: a nationwide cross-sectional survey. Transfusion. 2016 Dec;56(12):3033-3041. doi: 10.1111/trf.13887. Epub 2016 Nov 2.

    PMID: 27807857RESULT

MeSH Terms

Conditions

Wounds and InjuriesBlood Loss, SurgicalHematologic Diseases

Interventions

Blood Transfusion

Condition Hierarchy (Ancestors)

HemorrhagePathologic ProcessesPathological Conditions, Signs and SymptomsIntraoperative ComplicationsHemic and Lymphatic Diseases

Intervention Hierarchy (Ancestors)

Biological TherapyTherapeutics

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 29, 2017

First Posted

October 18, 2017

Study Start

November 1, 2011

Primary Completion

November 1, 2011

Study Completion

December 1, 2011

Last Updated

October 18, 2017

Record last verified: 2017-10